In this week's Smart Medicine Evidence Substack Update, I break down: What the committee actually recommended Why this matters What physicians and patients need to know today Why the sciencenot the headlinesshould guide clinical decisions The link to my latest Smart Medicine Substack is in the first comment
RTA + reductant Egg phosphatidylcholine liposomes (1.02 mM) (prepared as previously described 46 ), STY-BODIPY (1.02 M), inhibitor (4.07 M) and DTUN (0.203 mM) in cPBS (12 mM phosphate, 150 mM NaCl, pH 7.4) were added to the wells of a Nunc black polypropylene round-bottomed 96-well microplate (295 l)
BPC-157 in Inflammatory Bowel Disease (IBD) In ulcerative colitis and Crohns disease models, BPC-157 has: Reduced mucosal damage and bleeding Lowered inflammation markers Promoted rapid tissue healing Minimized recurrence of flare-ups 4
The most common polymorphisms of GSTM1-1 and GSTT1-1 gene loci consist in the complete deletion of the genes
These headaches often feel like throbbing pain with light sensitivity and visual problems
Nov-Dec 2005;56(6):904-10